BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 19566600)

  • 1. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies.
    Taylor CK; Levy RM; Elliott JC; Burnett BP
    Nutr Rev; 2009 Jul; 67(7):398-415. PubMed ID: 19566600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.
    Messina M; McCaskill-Stevens W; Lampe JW
    J Natl Cancer Inst; 2006 Sep; 98(18):1275-84. PubMed ID: 16985246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of soy intake and breast cancer risk.
    Trock BJ; Hilakivi-Clarke L; Clarke R
    J Natl Cancer Inst; 2006 Apr; 98(7):459-71. PubMed ID: 16595782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer.
    Messina M; Hilakivi-Clarke L
    Nutr Cancer; 2009; 61(6):792-8. PubMed ID: 20155618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group.
    Iwasaki M; Inoue M; Otani T; Sasazuki S; Kurahashi N; Miura T; Yamamoto S; Tsugane S;
    J Clin Oncol; 2008 Apr; 26(10):1677-83. PubMed ID: 18316793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer?
    Power KA; Thompson LU
    Mol Nutr Food Res; 2007 Jul; 51(7):845-56. PubMed ID: 17579892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy intake and cancer risk: a review of the in vitro and in vivo data.
    Messina MJ; Persky V; Setchell KD; Barnes S
    Nutr Cancer; 1994; 21(2):113-31. PubMed ID: 8058523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies.
    Park OJ; Surh YJ
    Toxicol Lett; 2004 Apr; 150(1):43-56. PubMed ID: 15068824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phytoestrogens and breast cancer: a complex story.
    Helferich WG; Andrade JE; Hoagland MS
    Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy isoflavone genistein in prevention and treatment of prostate cancer.
    Perabo FG; Von Löw EC; Ellinger J; von Rücker A; Müller SC; Bastian PJ
    Prostate Cancer Prostatic Dis; 2008; 11(1):6-12. PubMed ID: 17923857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic toxicity studies with genistein.
    Michael McClain R; Wolz E; Davidovich A; Bausch J
    Food Chem Toxicol; 2006 Jan; 44(1):42-55. PubMed ID: 16198038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect.
    Chang HC; Doerge DR
    Toxicol Appl Pharmacol; 2000 Nov; 168(3):244-52. PubMed ID: 11042097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics.
    Steiner C; Arnould S; Scalbert A; Manach C
    Br J Nutr; 2008 May; 99 E Suppl 1():ES78-108. PubMed ID: 18503737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha.
    Tonetti DA; Zhang Y; Zhao H; Lim SB; Constantinou AI
    Nutr Cancer; 2007; 58(2):222-9. PubMed ID: 17640169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soy isoflavones and their bone protective effects.
    Zhang Y; Chen WF; Lai WP; Wong MS
    Inflammopharmacology; 2008 Oct; 16(5):213-5. PubMed ID: 18815742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHI and WHIMS follow-up and human studies of soy isoflavones on cognition.
    Zhao L; Brinton RD
    Expert Rev Neurother; 2007 Nov; 7(11):1549-64. PubMed ID: 17997703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy for breast cancer survivors: a critical review of the literature.
    Messina MJ; Loprinzi CL
    J Nutr; 2001 Nov; 131(11 Suppl):3095S-108S. PubMed ID: 11694655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee.
    Sacks FM; Lichtenstein A; Van Horn L; Harris W; Kris-Etherton P; Winston M;
    Circulation; 2006 Feb; 113(7):1034-44. PubMed ID: 16418439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein alone or combined with cyclophosphamide may stimulate 16/C transplantable mouse mammary cancer growth.
    Wietrzyk J; Mazurkiewicz M; Madej J; Dzimira S; Grynkiewicz G; Radzikowski C; Opolski A
    Med Sci Monit; 2004 Nov; 10(11):BR414-9. PubMed ID: 15507846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and combinatory effects of soy isoflavones on the in vitro potentiation of lymphocyte activation.
    Wang W; Higuchi CM; Zhang R
    Nutr Cancer; 1997; 29(1):29-34. PubMed ID: 9383781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.